{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:11:02Z","timestamp":1761919862955},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s12016-014-8441-z","type":"journal-article","created":{"date-parts":[[2014,8,2]],"date-time":"2014-08-02T04:47:08Z","timestamp":1406954828000},"page":"1-5","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Unique Topics and Issues in Rheumatology and Clinical Immunology"],"prefix":"10.1007","volume":"47","author":[{"given":"Carlo","family":"Selmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,3]]},"reference":[{"key":"8441_CR1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12016-012-8314-2","volume":"44","author":"C Chang","year":"2013","unstructured":"Chang C, Gershwin ME (2013) Integrative medicine in allergy and immunology. Clin Rev Allergy Immunol 44:208\u2013228","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR2","doi-asserted-by":"crossref","unstructured":"Coop CA (2013) Immunotherapy for mold allergy. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8389-4","DOI":"10.1007\/s12016-013-8389-4"},{"key":"8441_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-013-8381-z","volume":"45","author":"C Selmi","year":"2013","unstructured":"Selmi C, Crotti C, Meroni PL (2013) Less travelled roads in clinical immunology and allergy: drug reactions and the environmental influence. Clin Rev Allergy Immunol 45:1\u20135","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-012-8310-6","volume":"45","author":"AK Verma","year":"2013","unstructured":"Verma AK, Kumar S, Das M, Dwivedi PD (2013) A comprehensive review of legume allergy. Clin Rev Allergy Immunol 45:30\u201346","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-013-8367-x","volume":"45","author":"SD Dickson","year":"2013","unstructured":"Dickson SD, Salazar KC (2013) Diagnosis and management of immediate hypersensitivity reactions to cephalosporins. Clin Rev Allergy Immunol 45:131\u2013142","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12016-010-8219-x","volume":"44","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Imazio M, Brizi MG et al (2013) Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol 44:6\u201313","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2012.12.010","volume":"41","author":"C Chang","year":"2013","unstructured":"Chang C (2013) The pathogenesis of neonatal autoimmune and autoinflammatory diseases: a comprehensive review. J Autoimmun 41:100\u2013110","journal-title":"J Autoimmun"},{"key":"8441_CR8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.autrev.2012.10.004","volume":"12","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Carubbi F, Liakouli V et al (2013) Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy. Autoimmun Rev 12:709\u2013716","journal-title":"Autoimmun Rev"},{"key":"8441_CR9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.autrev.2012.12.006","volume":"12","author":"C Comarmond","year":"2013","unstructured":"Comarmond C, Cacoub P (2013) Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies. Autoimmun Rev 12:752\u2013757","journal-title":"Autoimmun Rev"},{"key":"8441_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.autrev.2012.09.003","volume":"12","author":"M Gatto","year":"2013","unstructured":"Gatto M, Zen M, Ghirardello A et al (2013) Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 12:523\u2013536","journal-title":"Autoimmun Rev"},{"key":"8441_CR11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.autrev.2013.04.004","volume":"12","author":"SA Jimenez","year":"2013","unstructured":"Jimenez SA, Piera-Velazquez S (2013) Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjogren\u2019s syndrome. Autoimmun Rev 12:1046\u20131051","journal-title":"Autoimmun Rev"},{"key":"8441_CR12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","volume":"12","author":"A Marx","year":"2013","unstructured":"Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Strobel P (2013) The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 12:875\u2013884","journal-title":"Autoimmun Rev"},{"key":"8441_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jaut.2013.05.003","volume":"45","author":"S Pillai","year":"2013","unstructured":"Pillai S (2013) Rethinking mechanisms of autoimmune pathogenesis. J Autoimmun 45:97\u2013103","journal-title":"J Autoimmun"},{"key":"8441_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12016-012-8340-0","volume":"45","author":"JR Velazquez","year":"2013","unstructured":"Velazquez JR, Teran LM (2013) Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology. Clin Rev Allergy Immunol 45:75\u201386","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.autrev.2013.06.015","volume":"12","author":"Q Zhu","year":"2013","unstructured":"Zhu Q, Liu M, Dai L et al (2013) Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. Autoimmun Rev 12:1123\u20131128","journal-title":"Autoimmun Rev"},{"key":"8441_CR16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2013.05.002","volume":"44","author":"T Boettler","year":"2013","unstructured":"Boettler T, Pagni PP, Jaffe R, Cheng Y, Zerhouni P, von Herrath M (2013) The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes. J Autoimmun 44:40\u201348","journal-title":"J Autoimmun"},{"key":"8441_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2012.07.008","volume":"40","author":"R Iorio","year":"2013","unstructured":"Iorio R, Fryer JP, Hinson SR et al (2013) Astrocytic autoantibody of neuromyelitis optica (NMO-IgG) binds to aquaporin-4 extracellular loops, monomers, tetramers and high order arrays. J Autoimmun 40:21\u201327","journal-title":"J Autoimmun"},{"key":"8441_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2013.06.010","volume":"45","author":"A Katzav","year":"2013","unstructured":"Katzav A, Arango MT, Kivity S et al (2013) Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J Autoimmun 45:24\u201330","journal-title":"J Autoimmun"},{"key":"8441_CR19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2012.08.006","volume":"12","author":"RA Sinico","year":"2013","unstructured":"Sinico RA, Di Toma L, Radice A (2013) Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12:477\u2013482","journal-title":"Autoimmun Rev"},{"key":"8441_CR20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00296-006-0252-y","volume":"27","author":"M Fricker","year":"2007","unstructured":"Fricker M, Baumann A, Wermelinger F, Villiger PM, Helbling A (2007) A novel therapeutic option in Cogan diseases? TNF-alpha blockers. Rheumatol Int 27:493\u2013495","journal-title":"Rheumatol Int"},{"key":"8441_CR21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.autrev.2012.10.021","volume":"12","author":"F Atzeni","year":"2013","unstructured":"Atzeni F, Talotta R, Salaffi F et al (2013) Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev 12:703\u2013708","journal-title":"Autoimmun Rev"},{"key":"8441_CR22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.autrev.2012.03.010","volume":"12","author":"C Efe","year":"2013","unstructured":"Efe C (2013) Drug induced autoimmune hepatitis and TNF-alpha blocking agents: is there a real relationship? Autoimmun Rev 12:337\u2013339","journal-title":"Autoimmun Rev"},{"key":"8441_CR23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","volume":"12","author":"T Dimitroulas","year":"2013","unstructured":"Dimitroulas T, Nikas SN, Trontzas P, Kitas GD (2013) Biologic therapies and systemic bone loss in rheumatoid arthritis. Autoimmun Rev 12:958\u2013966","journal-title":"Autoimmun Rev"},{"key":"8441_CR24","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.autrev.2012.11.010","volume":"12","author":"OM Epis","year":"2013","unstructured":"Epis OM, Giacomelli L, Deidda S, Bruschi E (2013) Tight control applied to the biological therapy of rheumatoid arthritis. Autoimmun Rev 12:839\u2013841","journal-title":"Autoimmun Rev"},{"key":"8441_CR25","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.autrev.2012.11.011","volume":"12","author":"G Leardini","year":"2013","unstructured":"Leardini G, Rigon C (2013) The impact of the profile of biologics on treatment costs. Autoimmun Rev 12:842\u2013847","journal-title":"Autoimmun Rev"},{"key":"8441_CR26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.autrev.2012.11.009","volume":"12","author":"V Modena","year":"2013","unstructured":"Modena V, Bianchi G, Roccatello D (2013) Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: an achievable target? Autoimmun Rev 12:835\u2013838","journal-title":"Autoimmun Rev"},{"key":"8441_CR27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2012.08.013","volume":"12","author":"I Olivieri","year":"2013","unstructured":"Olivieri I, D\u2019Angelo S, Padula A, Leccese P, Nigro A, Palazzi C (2013) Can we reduce the dosage of biologics in spondyloarthritis? Autoimmun Rev 12:691\u2013693","journal-title":"Autoimmun Rev"},{"key":"8441_CR28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.autrev.2012.11.002","volume":"12","author":"D Roccatello","year":"2013","unstructured":"Roccatello D (2013) Novel diagnostic approaches and cost-benefit balance of treatment of immune-mediated and rare disease in the era of biologic drugs: lessons from the 15th Turin Congress on Immune Pathology and Orphan Disease. Autoimmun Rev 12:793\u2013795","journal-title":"Autoimmun Rev"},{"key":"8441_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12016-012-8301-7","volume":"44","author":"RK Sivamani","year":"2013","unstructured":"Sivamani RK, Goodarzi H, Garcia MS et al (2013) Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clin Rev Allergy Immunol 44:121\u2013140","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12016-013-8358-y","volume":"45","author":"A Soriano","year":"2013","unstructured":"Soriano A, Verecchia E, Afeltra A, Landolfi R, Manna R (2013) IL-1beta biological treatment of familial Mediterranean fever. Clin Rev Allergy Immunol 45:117\u2013130","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.autrev.2012.08.012","volume":"12","author":"E Fazzi","year":"2013","unstructured":"Fazzi E, Cattalini M, Orcesi S et al (2013) Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? Autoimmun Rev 12:506\u2013509","journal-title":"Autoimmun Rev"},{"key":"8441_CR32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12016-013-8362-2","volume":"45","author":"AD Islam","year":"2013","unstructured":"Islam AD, Naguwa SM, Cheema GS, Hunter JC, Gershwin ME (2013) Multicentric reticulohistiocytosis: a rare yet challenging disease. Clin Rev Allergy Immunol 45:281\u2013289","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.autrev.2013.03.014","volume":"12","author":"P Vermeersch","year":"2013","unstructured":"Vermeersch P, Bossuyt X (2013) Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmun Rev 12:998\u20131003","journal-title":"Autoimmun Rev"},{"key":"8441_CR34","doi-asserted-by":"crossref","unstructured":"Caetano-Lopes J, Rodrigues A, Lopes A et al (2013) Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8366-y","DOI":"10.1007\/s12016-013-8366-y"},{"key":"8441_CR35","doi-asserted-by":"crossref","unstructured":"Chighizola CB, Favalli E, Meroni PL (2013) Novel mechanisms of action of the biologicals in rheumatic diseases. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8359-x","DOI":"10.1007\/s12016-013-8359-x"},{"key":"8441_CR36","doi-asserted-by":"crossref","unstructured":"Macy E, Ngor E (2013) Recommendations for the management of beta-lactam intolerance. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8369-8","DOI":"10.1007\/s12016-013-8369-8"},{"key":"8441_CR37","doi-asserted-by":"crossref","unstructured":"Vadasz Z, Toubi E (2013) Semaphorins: their dual role in regulating immune-mediated diseases. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8360-4","DOI":"10.1007\/s12016-013-8360-4"},{"key":"8441_CR38","doi-asserted-by":"crossref","unstructured":"Vatti RR, Ali F, Teuber S, Chang C, Gershwin ME (2013) Hypersensitivity reactions to corticosteroids. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8365-z","DOI":"10.1007\/s12016-013-8365-z"},{"key":"8441_CR39","doi-asserted-by":"crossref","unstructured":"Alvarez-Rodriguez L, Lopez-Hoyos M, Carrasco-Marin E et al (2014) Cytokine gene considerations in giant cell arteritis: IL10 promoter polymorphisms and a review of the literature. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-013-8405-8"},{"key":"8441_CR40","doi-asserted-by":"crossref","unstructured":"Tayer-Shifman OE, Ilan O, Tovi H, Tal Y (2014) Cogan\u2019s syndrome-clinical guidelines and novel therapeutic approaches. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8406-7","DOI":"10.1007\/s12016-013-8406-7"},{"key":"8441_CR41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1034\/j.1398-9995.2000.00121.x","volume":"55","author":"M Matura","year":"2000","unstructured":"Matura M, Goossens A (2000) Contact allergy to corticosteroids. Allergy 55:698\u2013704","journal-title":"Allergy"},{"key":"8441_CR42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","volume":"12","author":"A Evoli","year":"2013","unstructured":"Evoli A, Padua L (2013) Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase. Autoimmun Rev 12:931\u2013935","journal-title":"Autoimmun Rev"},{"key":"8441_CR43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2013.06.016","volume":"46","author":"L Muratori","year":"2013","unstructured":"Muratori L, Longhi MS (2013) The interplay between regulatory and effector T cells in autoimmune hepatitis: implications for innovative treatment strategies. J Autoimmun 46:74\u201380","journal-title":"J Autoimmun"},{"key":"8441_CR44","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.autrev.2012.11.012","volume":"12","author":"A Pani","year":"2013","unstructured":"Pani A (2013) Standard immunosuppressive therapy of immune-mediated glomerular diseases. Autoimmun Rev 12:848\u2013853","journal-title":"Autoimmun Rev"},{"key":"8441_CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12016-012-8303-5","volume":"44","author":"V Chandran","year":"2013","unstructured":"Chandran V (2013) The genetics of psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol 44:149\u2013156","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR46","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12016-012-8346-7","volume":"45","author":"J Kurko","year":"2013","unstructured":"Kurko J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z (2013) Genetics of rheumatoid arthritis\u2014a comprehensive review. Clin Rev Allergy Immunol 45:170\u2013179","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s12016-013-8398-3","volume":"45","author":"Y Liu","year":"2013","unstructured":"Liu Y, Li H, Xiao T, Lu Q (2013) Epigenetics in immune-mediated pulmonary diseases. Clin Rev Allergy Immunol 45:314\u2013330","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2013.01.010","volume":"41","author":"Q Lu","year":"2013","unstructured":"Lu Q (2013) The critical importance of epigenetics in autoimmunity. J Autoimmun 41:1\u20135","journal-title":"J Autoimmun"},{"key":"8441_CR49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2013.01.012","volume":"41","author":"Y Luo","year":"2013","unstructured":"Luo Y, Wang Y, Wang Q, Xiao R, Lu Q (2013) Systemic sclerosis: genetics and epigenetics. J Autoimmun 41:161\u2013167","journal-title":"J Autoimmun"},{"key":"8441_CR50","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.autrev.2013.04.003","volume":"12","author":"D Rigante","year":"2013","unstructured":"Rigante D, Castellazzi L, Bosco A, Esposito S (2013) Is there a crossroad between infections, genetics, and Henoch-Schonlein purpura? Autoimmun Rev 12:1016\u20131021","journal-title":"Autoimmun Rev"},{"key":"8441_CR51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2012.12.013","volume":"41","author":"Y Ando","year":"2013","unstructured":"Ando Y, Yang GX, Kenny TP et al (2013) Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse. J Autoimmun 41:111\u2013119","journal-title":"J Autoimmun"},{"key":"8441_CR52","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12016-013-8356-0","volume":"45","author":"Y Arnson","year":"2013","unstructured":"Arnson Y, Itzhaky D, Mosseri M et al (2013) Vitamin D inflammatory cytokines and coronary events: a comprehensive review. Clin Rev Allergy Immunol 45:236\u2013247","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR53","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.autrev.2012.10.001","volume":"12","author":"EY Lee","year":"2013","unstructured":"Lee EY, Lee ZH, Song YW (2013) The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmun Rev 12:554\u2013557","journal-title":"Autoimmun Rev"},{"key":"8441_CR54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2012.12.003","volume":"41","author":"MS Longhi","year":"2013","unstructured":"Longhi MS, Ma Y, Grant CR et al (2013) T-regs in autoimmune hepatitis-systemic lupus erythematosus\/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile. J Autoimmun 41:146\u2013151","journal-title":"J Autoimmun"},{"key":"8441_CR55","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12016-012-8306-2","volume":"44","author":"A Mitra","year":"2013","unstructured":"Mitra A, Fallen RS, Lima HC (2013) Cytokine-based therapy in psoriasis. Clin Rev Allergy Immunol 44:173\u2013182","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR56","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.autrev.2013.02.003","volume":"12","author":"LT Osnes","year":"2013","unstructured":"Osnes LT, Nakken B, Bodolay E, Szodoray P (2013) Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies\u2014novel tool for diagnostics and patient follow-up. Autoimmun Rev 12:967\u2013971","journal-title":"Autoimmun Rev"},{"key":"8441_CR57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaut.2013.01.011","volume":"42","author":"PJ Gardner","year":"2013","unstructured":"Gardner PJ, Joshi L, Lee RW, Dick AD, Adamson P, Calder VL (2013) SIRT1 activation protects against autoimmune T cell-driven retinal disease in mice via inhibition of IL-2\/Stat5 signaling. J Autoimmun 42:117\u2013129","journal-title":"J Autoimmun"},{"key":"8441_CR58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2012.09.001","volume":"40","author":"GA Liubchenko","year":"2013","unstructured":"Liubchenko GA, Appleberry HC, Striebich CC et al (2013) Rheumatoid arthritis is associated with signaling alterations in naturally occurring autoreactive B-lymphocytes. J Autoimmun 40:111\u2013121","journal-title":"J Autoimmun"},{"key":"8441_CR59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2013.06.009","volume":"44","author":"A Satake","year":"2013","unstructured":"Satake A, Schmidt AM, Archambault A, Leichner TM, Wu GF, Kambayashi T (2013) Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells. J Autoimmun 44:13\u201320","journal-title":"J Autoimmun"},{"key":"8441_CR60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaut.2012.07.009","volume":"40","author":"JO Jin","year":"2013","unstructured":"Jin JO, Han X, Yu Q (2013) Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun 40:28\u201344","journal-title":"J Autoimmun"},{"key":"8441_CR61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2013.04.001","volume":"44","author":"JR Podojil","year":"2013","unstructured":"Podojil JR, Liu LN, Marshall SA et al (2013) B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10\/Treg-dependent mechanisms. J Autoimmun 44:71\u201381","journal-title":"J Autoimmun"},{"key":"8441_CR62","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-011-8296-5","volume":"44","author":"RC Axtell","year":"2013","unstructured":"Axtell RC, Raman C, Steinman L (2013) Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin Rev Allergy Immunol 44:114\u2013120","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2012.07.004","volume":"40","author":"PM Dias","year":"2013","unstructured":"Dias PM, Banerjee G (2013) The role of Th17\/IL-17 on eosinophilic inflammation. J Autoimmun 40:9\u201320","journal-title":"J Autoimmun"},{"key":"8441_CR64","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2013.08.002","volume":"47","author":"J Xiao","year":"2013","unstructured":"Xiao J, Liu C, Li G et al (2013) PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses. J Autoimmun 47:34\u201344","journal-title":"J Autoimmun"},{"key":"8441_CR65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12016-012-8307-1","volume":"44","author":"SP Raychaudhuri","year":"2013","unstructured":"Raychaudhuri SP (2013) Role of IL-17 in psoriasis and psoriatic arthritis. Clin Rev Allergy Immunol 44:183\u2013193","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR66","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.autrev.2012.10.020","volume":"12","author":"F Atzeni","year":"2013","unstructured":"Atzeni F, Benucci M, Salli S, Bongiovanni S, Boccassini L, Sarzi-Puttini P (2013) Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev 12:575\u2013579","journal-title":"Autoimmun Rev"},{"key":"8441_CR67","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.autrev.2013.06.011","volume":"12","author":"F Atzeni","year":"2013","unstructured":"Atzeni F, Sarzi-Puttini P, Mutti A, Bugatti S, Cavagna L, Caporali R (2013) Long-term safety of abatacept in patients with rheumatoid arthritis. Autoimmun Rev 12:1115\u20131117","journal-title":"Autoimmun Rev"},{"key":"8441_CR68","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.autrev.2013.01.001","volume":"12","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Nadler SG (2013) Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis. Autoimmun Rev 12:758\u2013767","journal-title":"Autoimmun Rev"},{"key":"8441_CR69","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","volume":"382","author":"IB McInnes","year":"2013","unstructured":"McInnes IB, Kavanaugh A, Gottlieb AB et al (2013) Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1\u00a0year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 382:780\u2013789","journal-title":"Lancet"},{"key":"8441_CR70","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/annrheumdis-2013-204741","volume":"73","author":"A Kavanaugh","year":"2014","unstructured":"Kavanaugh A, Ritchlin C, Rahman P et al (2014) Ustekinumab, an anti-IL-12\/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials. Ann Rheum Dis 73:1000\u20131006","journal-title":"Ann Rheum Dis"},{"key":"8441_CR71","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"C Ritchlin","year":"2014","unstructured":"Ritchlin C, Rahman P, Kavanaugh A et al (2014) Efficacy and safety of the anti-IL-12\/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann Rheum Dis 73:990\u2013999","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"8441_CR72","doi-asserted-by":"crossref","first-page":"ii116","DOI":"10.1136\/annrheumdis-2012-202371","volume":"72","author":"DD Patel","year":"2013","unstructured":"Patel DD, Lee DM, Kolbinger F, Antoni C (2013) Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann Rheum Dis 72(Suppl 2):ii116\u2013ii123","journal-title":"Ann Rheum Dis"},{"key":"8441_CR73","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/imm.12142","volume":"141","author":"BW Kirkham","year":"2014","unstructured":"Kirkham BW, Kavanaugh A, Reich K (2014) Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology 141:133\u2013142","journal-title":"Immunology"},{"key":"8441_CR74","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-202646","volume":"73","author":"IB McInnes","year":"2014","unstructured":"McInnes IB, Sieper J, Braun J et al (2014) Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial. Ann Rheum Dis 73:349\u2013356","journal-title":"Ann Rheum Dis"},{"key":"8441_CR75","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","volume":"370","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Genovese MC, Greenwald MW et al (2014) Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis. N Engl J Med 370:2295\u20132306","journal-title":"N Engl J Med"},{"key":"8441_CR76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2013.08.008","volume":"47","author":"CT Mayer","year":"2013","unstructured":"Mayer CT, Huntenburg J, Nandan A, Schmitt E, Czeloth N, Sparwasser T (2013) CD4 blockade directly inhibits mouse and human CD4(+) T cell functions independent of Foxp3(+) Tregs. J Autoimmun 47:73\u201382","journal-title":"J Autoimmun"},{"key":"8441_CR77","doi-asserted-by":"crossref","unstructured":"Yi JS, Guidon A, Sparks S et al (2013) Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis. J Autoimmun. doi: 10.1016\/j.jaut.2013.12.005","DOI":"10.1016\/j.jaut.2013.12.005"},{"key":"8441_CR78","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaut.2013.01.004","volume":"41","author":"M Zhao","year":"2013","unstructured":"Zhao M, Liu Q, Liang G et al (2013) E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients. J Autoimmun 41:152\u2013160","journal-title":"J Autoimmun"},{"key":"8441_CR79","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaut.2013.01.005","volume":"41","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q (2013) Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus. J Autoimmun 41:92\u201399","journal-title":"J Autoimmun"},{"key":"8441_CR80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12016-011-8268-9","volume":"44","author":"R Gualtierotti","year":"2013","unstructured":"Gualtierotti R, Biggioggero M, Meroni PL (2013) Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome. Clin Rev Allergy Immunol 44:51\u201356","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR81","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.autrev.2013.03.013","volume":"12","author":"I Hollan","year":"2013","unstructured":"Hollan I, Meroni PL, Ahearn JM et al (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12:1004\u20131015","journal-title":"Autoimmun Rev"},{"key":"8441_CR82","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.autrev.2013.02.004","volume":"12","author":"P Pludowski","year":"2013","unstructured":"Pludowski P, Holick MF, Pilz S et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev 12:976\u2013989","journal-title":"Autoimmun Rev"},{"key":"8441_CR83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12016-010-8251-x","volume":"44","author":"E Bartoloni","year":"2013","unstructured":"Bartoloni E, Alunno A, Bistoni O, Gerli R (2013) Cardiovascular risk in rheumatoid arthritis and systemic autoimmune rheumatic disorders: a suggested model of preventive strategy. Clin Rev Allergy Immunol 44:14\u201322","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR84","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12016-010-8233-z","volume":"44","author":"P Roux-Lombard","year":"2013","unstructured":"Roux-Lombard P, Pagano S, Montecucco F, Satta N, Vuilleumier N (2013) Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases. Clin Rev Allergy Immunol 44:84\u201397","journal-title":"Clin Rev Allergy Immunol"},{"key":"8441_CR85","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.autrev.2012.10.008","volume":"12","author":"S Mihai","year":"2013","unstructured":"Mihai S, Nimmerjahn F (2013) The role of Fc receptors and complement in autoimmunity. Autoimmun Rev 12:657\u2013660","journal-title":"Autoimmun Rev"},{"key":"8441_CR86","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","volume":"12","author":"E Tuzun","year":"2013","unstructured":"Tuzun E, Christadoss P (2013) Complement associated pathogenic mechanisms in myasthenia gravis. Autoimmun Rev 12:904\u2013911","journal-title":"Autoimmun Rev"},{"key":"8441_CR87","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jaut.2013.01.003","volume":"42","author":"R Huda","year":"2013","unstructured":"Huda R, Tuzun E, Christadoss P (2013) Complement C2 siRNA mediated therapy of myasthenia gravis in mice. J Autoimmun 42:94\u2013104","journal-title":"J Autoimmun"},{"key":"8441_CR88","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.autrev.2012.07.012","volume":"12","author":"A Greco","year":"2013","unstructured":"Greco A, Gallo A, Fusconi M et al (2013) Cogan\u2019s syndrome: an autoimmune inner ear disease. Autoimmun Rev 12:396\u2013400","journal-title":"Autoimmun Rev"},{"key":"8441_CR89","doi-asserted-by":"crossref","unstructured":"Saito Y, Saito H, Liang G, Friedman JM (2013) Epigenetic alterations and microRNA misexpression in cancer and autoimmune diseases: a critical review. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-013-8401-z","DOI":"10.1007\/s12016-013-8401-z"},{"key":"8441_CR90","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2013.04.003","volume":"43","author":"P Coit","year":"2013","unstructured":"Coit P, Jeffries M, Altorok N et al (2013) Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naive CD4+ T cells from lupus patients. J Autoimmun 43:78\u201384","journal-title":"J Autoimmun"},{"key":"8441_CR91","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaut.2012.12.004","volume":"41","author":"H Katoh","year":"2013","unstructured":"Katoh H, Zheng P, Liu Y (2013) FOXP3: genetic and epigenetic implications for autoimmunity. J Autoimmun 41:72\u201378","journal-title":"J Autoimmun"},{"key":"8441_CR92","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jaut.2013.02.002","volume":"41","author":"Y Thabet","year":"2013","unstructured":"Thabet Y, Le Dantec C, Ghedira I et al (2013) Epigenetic dysregulation in salivary glands from patients with primary Sjogren\u2019s syndrome may be ascribed to infiltrating B cells. J Autoimmun 41:175\u2013181","journal-title":"J Autoimmun"},{"key":"8441_CR93","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","volume":"41","author":"Q Wang","year":"2013","unstructured":"Wang Q, Selmi C, Zhou X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140\u2013145","journal-title":"J Autoimmun"},{"key":"8441_CR94","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jaut.2012.12.005","volume":"41","author":"L Rica de la","year":"2013","unstructured":"de la Rica L, Urquiza JM, Gomez-Cabrero D et al (2013) Identification of novel markers in rheumatoid arthritis through integrated analysis of DNA methylation and microRNA expression. J Autoimmun 41:6\u201316","journal-title":"J Autoimmun"},{"key":"8441_CR95","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2013.02.002","volume":"12","author":"D Saadoun","year":"2013","unstructured":"Saadoun D, Bodaghi B, Bienvenu B et al (2013) Biotherapies in inflammatory ocular disorders: interferons, immunoglobulins, monoclonal antibodies. Autoimmun Rev 12:774\u2013783","journal-title":"Autoimmun Rev"},{"key":"8441_CR96","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.autrev.2012.08.016","volume":"12","author":"M Visentini","year":"2013","unstructured":"Visentini M, Conti V, Cristofoletti C et al (2013) Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity. Autoimmun Rev 12:430\u2013435","journal-title":"Autoimmun Rev"},{"key":"8441_CR97","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2013.08.007","volume":"47","author":"K Wichner","year":"2013","unstructured":"Wichner K, Fischer A, Winter S et al (2013) Transition from an autoimmune-prone state to fatal autoimmune disease in CCR7 and RORgammat double-deficient mice is dependent on gut microbiota. J Autoimmun 47:58\u201372","journal-title":"J Autoimmun"},{"key":"8441_CR98","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2013.07.001","volume":"46","author":"J Henao-Mejia","year":"2013","unstructured":"Henao-Mejia J, Elinav E, Thaiss CA, Licona-Limon P, Flavell RA (2013) Role of the intestinal microbiome in liver disease. J Autoimmun 46:66\u201373","journal-title":"J Autoimmun"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8441-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-014-8441-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-014-8441-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:48:57Z","timestamp":1559440137000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-014-8441-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["8441"],"URL":"https:\/\/doi.org\/10.1007\/s12016-014-8441-z","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}